Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1636 to 1650 of 7681 results

  1. Optilume for treating recurrent bulbar urethral strictures (MTG73)

    Evidence-based recommendations on Optilume for treating recurrent bulbar urethral strictures.

    Medical technologies guidance
    Published
    29 November 2022
    View recommendations

    Sections for MTG73

  2. GreenLight XPS for treating benign prostatic hyperplasia (MTG74)

    Evidence-based recommendations on GreenLight XPS for benign prostatic hyperplasia.

    Medical technologies guidance
    Published
    29 November 2022
    View recommendations

    Sections for MTG74

  3. The PLASMA system for transurethral resection and haemostasis of the prostate (MTG53)

    Evidence-based recommendations on the PLASMA system for transurethral resection and haemostasis of the prostate.

    Medical technologies guidance
    Published
    6 January 2021
    View recommendations

    Sections for MTG53

  4. The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal (MTG54)

    Evidence-based recommendations on the VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal.

    Medical technologies guidance
    Published
    27 January 2021
    View recommendations

    Sections for MTG54

  5. Leukomed Sorbact for preventing surgical site infection (MTG55)

    Evidence-based recommendations on Leukomed Sorbact for preventing surgical site infection after caesarean section or vascular surgery.

    Medical technologies guidance
    Published
    3 February 2021
    View recommendations

    Sections for MTG55

  6. Danis stent for acute oesophageal variceal bleeding (MTG57)

    Evidence-based recommendations on Danis stent for acute oesophageal variceal bleeding.

    Medical technologies guidance
    Published
    31 March 2021
    View recommendations

    Sections for MTG57

  7. Plus Sutures for preventing surgical site infection (MTG59)

    Evidence-based recommendations on Plus Sutures for preventing surgical site infection.

    Medical technologies guidance
    Published
    28 June 2021
    View recommendations

    Sections for MTG59

  8. Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 TS ID 11827

    Awaiting development [GID-TA11313] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. ABP 959 (eculizumab biosimilar) for treating paroxysmal nocturnal haemoglobinuria TS ID 10250

      Status ...

    Technology appraisal guidance
    Topic selection

  10. STS101 for treating acute migraine TS ID 11782

    Awaiting development [GID-TA11147] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Paclitaxel + XR17 (Paclical) with carboplatin for ovarian cancer TS ID 5462

      Status ...

    Technology appraisal guidance
    Topic selection

  12. Riluzole oral film for treating amyotrophic lateral sclerosis TS ID 11779

      Status ...

    Technology appraisal guidance
    Topic selection

  13. Gantenerumab for treating early Alzheimer's disease TS ID 10668

    Awaiting development [GID-TA11072] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Dersimelagon for treating erythropoietic protoporphyria and X-linked protoporphyria in people 12 years and over TS ID 10392

    Awaiting development [GID-TA11085] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Crizanlizumab for preventing recurrent vaso-occlusive crises in sickle cell disease in young people aged 12 to 17 TS ID 10766

      Status ...

    Technology appraisal guidance
    Topic selection